These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1012 related articles for article (PubMed ID: 9262225)

  • 1. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease.
    Matsuura N; Harada S; Ohyama Y; Shibayama K; Fukushi M; Ishikawa N; Yuri K; Nakanishi M; Yokota Y; Kazahari K; Oguchi H
    Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease.
    Higuchi R; Kumagai T; Kobayashi M; Minami T; Koyama H; Ishii Y
    Pediatrics; 2001 Apr; 107(4):E57. PubMed ID: 11335778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of perinatal asphyxia on thyroid-stimulating hormone and thyroid hormone levels.
    Pereira DN; Procianoy RS
    Acta Paediatr; 2003; 92(3):339-45. PubMed ID: 12725550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy.
    Momotani N; Hisaoka T; Noh J; Ishikawa N; Ito K
    J Clin Endocrinol Metab; 1992 Sep; 75(3):738-44. PubMed ID: 1517362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
    Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
    Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of newborns of mothers with Graves' disease.
    Levy-Shraga Y; Tamir-Hostovsky L; Boyko V; Lerner-Geva L; Pinhas-Hamiel O
    Thyroid; 2014 Jun; 24(6):1032-9. PubMed ID: 24472020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Central congenital hypothyroidism due to Graves' disease in the mother].
    Liebrand CA; de Mol AC; Kempers MJ; Noordam C
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2229-32. PubMed ID: 17076354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foetal and neonatal thyroid disorders.
    Radetti G; Zavallone A; Gentili L; Beck-Peccoz P; Bona G
    Minerva Pediatr; 2002 Oct; 54(5):383-400. PubMed ID: 12244277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of transient postnatal hypothyroxinemia in premature infants with and without respiratory distress syndrome.
    Hadeed AJ; Asay LD; Klein AH; Fisher DA
    Pediatrics; 1981 Oct; 68(4):494-8. PubMed ID: 6798539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for developmental disorders in infants born to women with Graves disease.
    Mitsuda N; Tamaki H; Amino N; Hosono T; Miyai K; Tanizawa O
    Obstet Gynecol; 1992 Sep; 80(3 Pt 1):359-64. PubMed ID: 1379702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated free thyroxine levels detected by a neonatal screening system.
    Tajima T; Jo W; Fujikura K; Fukushi M; Fujieda K
    Pediatr Res; 2009 Sep; 66(3):312-6. PubMed ID: 19542904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications.
    Bayer MF; Kriss JP; McDougall IR
    J Nucl Med; 1985 Nov; 26(11):1248-56. PubMed ID: 3840528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease.
    Wan Nazaimoon WM; Khalid BA
    Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective method for prediction of transient hypothyroidism in neonates born to mothers with chronic thyroiditis.
    Tamaki H; Amino N; Aozasa M; Mori M; Iwatani Y; Tachi J; Nose O; Tanizawa O; Miyai K
    Am J Perinatol; 1989 Jul; 6(3):296-303. PubMed ID: 2567172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone in hypopituitarism, Graves' disease, congenital hypothyroidism, and maternal thyroid disease during pregnancy.
    LaFranchi S
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S20-4. PubMed ID: 16707271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for neonatal thyroid dysfunction in pregnancies complicated by Graves' disease.
    Uenaka M; Tanimura K; Tairaku S; Morioka I; Ebina Y; Yamada H
    Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():89-93. PubMed ID: 24726178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome.
    Idris I; Srinivasan R; Simm A; Page RC
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):560-5. PubMed ID: 16268809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital thyrotoxicosis in premature infants.
    Smith C; Thomsett M; Choong C; Rodda C; McIntyre HD; Cotterill AM
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):371-6. PubMed ID: 11298090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease.
    Kempers MJ; van Trotsenburg AS; van Rijn RR; Smets AM; Smit BJ; de Vijlder JJ; Vulsma T
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2984-91. PubMed ID: 17504907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.